Getinge (OTCMKTS:GNGBY) Sets New 1-Year High - Here's What Happened

Getinge logo with Healthcare background
Image from MarketBeat Media, LLC.

Key Points

  • Getinge shares reached a new 52-week high of $28.03, up from the previous close of $26.82, with 408 shares traded.
  • Analyst sentiment is currently cautious: four analysts rate the stock Hold, following several recent rating downgrades from Buy or Strong Buy.
  • Getinge reported quarterly earnings of $0.32 per share on revenue of $875.58 million. Analysts expect full-year earnings of approximately $1.36 per share.
  • Interested in Getinge? Here are five stocks we like better.

Getinge (OTCMKTS:GNGBY - Get Free Report)'s stock price reached a new 52-week high during trading on Monday. The stock traded as high as $28.03 and last traded at $28.03, with a volume of 408 shares traded. The stock had previously closed at $26.82.

Wall Street Analysts Forecast Growth

GNGBY has been the topic of several recent research reports. Zacks Research cut shares of Getinge from a "strong-buy" rating to a "hold" rating in a research report on Thursday, September 17th. Pareto Securities lowered Getinge from a "strong-buy" rating to a "hold" rating in a report on Thursday, September 24th. UBS Group began coverage on Getinge in a research note on Wednesday, September 2nd. They issued a "hold" rating for the company. Finally, Nordea Equity Research lowered Getinge from a "buy" rating to a "hold" rating in a report on Monday, August 31st. Four analysts have rated the stock with a Hold rating. According to MarketBeat.com, the stock presently has a consensus rating of "Hold".

Read Our Latest Report on GNGBY

Getinge Trading Up 2.3%

The company has a current ratio of 1.31, a quick ratio of 0.74 and a debt-to-equity ratio of 0.26. The stock has a market cap of $7.62 billion, a PE ratio of 25.42 and a beta of 0.89. The firm has a fifty day simple moving average of $25.38 and a two-hundred day simple moving average of $22.61.

Getinge (OTCMKTS:GNGBY - Get Free Report) last posted its quarterly earnings data on Wednesday, October 21st. The company reported $0.32 earnings per share for the quarter. The firm had revenue of $875.58 million for the quarter. Getinge had a net margin of 8.20% and a return on equity of 11.55%. As a group, equities analysts expect that Getinge will post 1.36 earnings per share for the current fiscal year.

Getinge Company Profile

(Get Free Report)

Getinge AB is a Sweden-based medical technology company that develops products and solutions for hospitals, healthcare providers and life sciences organizations. Its offerings are designed to support patient care, surgical procedures, infection prevention and the development and production of pharmaceuticals and other medical products.

The company's portfolio includes equipment for intensive care and cardiovascular procedures, operating-room systems, surgical instruments, sterilization and disinfection solutions, and products used in laboratories and biopharmaceutical manufacturing.

See Also

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Getinge Right Now?

Before you consider Getinge, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Getinge wasn't on the list.

While Getinge currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Don't Wait for the OpenAI IPO Cover

The AI wave will soon hit public markets with Anthropic and OpenAI set to go public later this year. However, you don't have to wait to invest. This report shows seven AI stocks that you can buy today while the big model providers get ready to go public.

Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines